BAY 43-9006 ≥98% (by NMR)

Supplier: ADIPOGEN CORP MS
Warning

Synonyms: 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide, Sorafenib, N-[4-Chloro-3-(trifluoromethyl)phenyl]-N′-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide

AG-CR1-0025-M001 AG-CR1-0025-M005 AG-CR1-0025-M025
102515-964EA 20.77 USD
102515-964 102515-966 102515-968
BAY 43-9006 ≥98% (by NMR)
Sorafenib (BAY 43-9006)

Antitumor compound. Broad-spectrum kinase inhibitor. Raf kinase inhibitor. Apoptosis inducer. Cytostatic. Angiogenesis inhibitor. Review.

Formula: C₂₁H₁₆ClF₃N₄O₃
MW: 464.82 g/mol
Storage Temperature: Freezer
MDL Number: MFCD06411450
CAS Number: 284461-73-0

Order Now

Specification Test Results

Purity 98% (NMR)
Appearance/Color White to off-white solid.
Solubility Soluble in DMSO, 100% ethanol, methanol or ethyl acetate.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR